Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 24, 2024
Regular
exercise
enhances
life
quality,
lowers
the
risk
of
cognitive
damage,
and
slows
advancement
Alzheimer's
disease
(AD).
Natural
compounds
rich
in
polyphenols
have
garnered
attention
as
a
non-pharmacological
means
treating
preventing
AD.
The
primary
component
wine,
grape
seeds,
nuts
is
polyphenols.
Research
suggests
that
slow
down
rate
neurodegeneration
AD
lessen
learning
impairment.
Furthermore,
brain
impairments
related
to
cognition.
Additionally,
can
specifically
restructure
amyloid-β
(Aβ)
structures
soluble
oligomers
into
non-toxic
alternative
species.
They
also
been
revealed
increase
brain-derived
neurotrophic
factors
expression,
suggesting
they
positive
impact
on
creation
neurotrophins.
benefits
polyphenol
supplementation
exercise,
which
both
provide
neuroprotection,
not
well
studied
patients.
This
review
aimed
investigate
effects
combined
inflammation,
several
conformational
toxic
species
Aβ,
Aβ-induced
apoptosis
Toxicology Reports,
Journal Year:
2024,
Volume and Issue:
13, P. 101715 - 101715
Published: Aug. 23, 2024
Alzheimer's
disease
(AD)
is
a
major
cause
of
disability
and
one
the
top
causes
mortality
globally.
AD
remains
public
health
challenge
due
to
its
prevalence,
impact
on
patients
caregivers,
current
lack
cure.
In
recent
years,
polyphenols
have
garnered
attention
for
their
potential
therapeutic
effects
AD.
The
objective
study
was
establish
network
pharmacology
between
selected
plant
origin
Insilico
tools
such
as
SwissADME,
ProTox3.0,
pkCSM,
Swiss
Target
Prediction,
DisGeNET,
InterActiVenn,
DAVID
database,
STRING
Cytoscape/CytoHubba
were
employed
multi-target
polyphenolic
compounds.
present
revealed
that
out
17
polyphenols,
10
ligands
found
possess
drug-likeness
nature
along
with
desirable
pharmacokinetic
parameters
lesser
toxicity
profile.
Also,
results
highlighted
possible
interactions
targets
involved
in
Further,
this
has
shed
light
mTOR
pathway
through
autophagic
mechanism.
Overall,
indicated
could
be
better
option
treating
Hence,
consumption
cocktails
part
diet
produce
more
effective
outcomes
against
disease.
Additional
studies
are
warranted
future
explore
additional
pathways
genes
provide
comprehensive
understanding
regarding
usage
shortlisted
derivatives
prevention
treatment
Exploration of neuroscience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 24, 2025
Neurodegenerative
disorders,
including
Alzheimer’s,
Parkinson’s,
Huntington’s,
and
amyotrophic
lateral
sclerosis,
are
among
the
most
significant
health
concerns
worldwide,
characterized
by
neuronal
dysfunction,
oxidative
stress,
neuroinflammation,
protein
misfolding.
Epigallocatechin
gallate,
a
green
tea
polyphenol,
has
been
reported
to
possess
multifaceted
neuroprotective
properties.
It
reduces
stress
through
free
radical
scavenging,
activation
of
antioxidant
enzymes,
stabilization
mitochondrial
function.
also
inhibits
neuroinflammation
modulation
key
signaling
pathways.
suppresses
amyloid-beta
aggregation
in
Alzheimer’s
alpha-synuclein
fibrillation
thus
attenuating
toxic
accumulation.
Its
activity
induction
autophagy
promotion
synaptic
plasticity
supports
survival
However,
low
bioavailability
metabolic
instability
hinder
its
translation
into
clinic.
Strategies
nanoparticle
encapsulation,
structural
modifications,
combination
therapies
being
explored
overcome
these
challenges.
Future
research
could
establish
epigallocatechin
gallate
as
viable
candidate
for
managing
neurodegenerative
disorders.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 4271 - 4271
Published: April 30, 2025
The
brain-derived
neurotrophic
factor
(BDNF)
has
become
one
of
the
cornerstones
neuropathology,
influencing
synaptic
plasticity,
cognitive
resilience,
and
neuronal
survival.
Apart
from
its
molecular
biology,
BDNF
is
a
powerful
target
for
transformative
benefit
in
precision
medicine,
leading
to
innovative
therapeutic
approaches
neurodegenerative
psychiatric
diseases
like
Alzheimer's
disease
(AD),
Parkinson's
(PD),
major
depressive
disorder
(MDD),
post-traumatic
stress
(PTSD).
Nevertheless,
clinical
applicability
obstructed
by
hurdles
delivery,
patient-specific
diversity,
pleiotropic
signaling.
Here,
we
summarize
findings
research,
including
regulatory
pathways
diagnostic/prognostic
biomarkers
integrative
approaches.
We
describe
delivery
systems,
such
as
lipid
nanoparticle-based
mRNA
therapies
CRISPR-dCas9-based
epigenetic
editing
that
bypass
obstacles
BBB
(blood-brain
barrier)
enzymatic
degradation.
recent
implementation
multiplex
panels
combining
biodynamic
indicators
with
tau
amyloid-β
signaling
markers
showcases
novel
levels
specificity
both
early
detection
potential
monitoring.
Humanized
preclinical
models
iPSC-derived
neurons
organoids
point
key
role
neurodeveloping
processes,
paralleling
advances
bridging
observation
environments.
Moreover,
tools
delivering
TrkB
activators
or
AI-based
dynamic
care
platforms
enable
tailored
scalable
treatments.
This
review
also
aims
extend
framework
used
understanding
BDNF's
relevance
traditional
situating
more
work
detailing
actions
ischemic
tissues
gut-brain
axis
context
systemic
health.
Finally,
outline
roadmap
incorporation
BDNF-centered
into
worldwide
healthcare,
highlighting
ethical
issues,
equity,
interdisciplinary
decomposition.
heralds
new
era
neuroscience
revolutionizing
brain
health
paving
way
advancement
medicine.
BMC Complementary Medicine and Therapies,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: May 17, 2025
Alzheimer's
disease
(AD)
is
a
progressive
neurodegenerative
disorder
characterized
by
cholinergic
dysfunction,
neuroinflammation,
oxidative
stress,
and
memory
impairment.
The
Salvia
genus
has
been
used
since
ancient
times
for
its
anti-inflammatory
neuroprotective
properties.
In
this
study,
we
aimed
to
investigate
the
effects
of
aristata
hydroalcoholic
extract
(SAHE)
dichloromethane
(SADE)
on
various
aspects
AD.
Column
chromatography
was
utilized
in
phytochemical
analysis
isolate
purify
bioactive
compounds.
structures
isolated
compounds
were
determined
through
spectroscopic
techniques,
including
1D
2D
NMR,
along
with
IR,
UV,
HRESIMS
new
compound.
Cholinesterase
inhibitory
activity
assessed
using
modified
Ellman's
method.
Additionally,
antioxidant
metal
chelation
capacity
SAHE
SADE
evaluated
DPPH
assay
methods,
respectively.
Moreover,
PC12
cells
investigated
AlamarBlue
assay,
ability
mitigate
scopolamine-induced
impairment
rats
Morris
water
maze
(MWM)
test.
structurally
elucidated
an
undescribed
compound,
namely
salvinarin
(2),
as
well
four
known
linariin
(1),
pectolinarin
(3),
scutellarein
4'-O-methyl-7-O-rutinoside
(4),
5-O-coumaroylquinic
acid
(5)
from
first
time.
vitro
analyses
revealed
that
SAHE,
SADE,
exhibited
significant
against
H2O2-induced
cytotoxicity
cells.
Notably,
demonstrated
potent
acetylcholinesterase
(AChE)
inhibition
(IC50
=
322.83
±
1.11
µg/mL),
99.16
1.24
strong
chelating
toward
Cu2+,
Zn2+,
Fe2+.
oral
administration
(400
mg/kg/day)
significantly
ameliorated
induced
scopolamine
rat
model.
This
improvement
evident
parameters
such
traveled
distance
(p
<
0.001),
escape
latency
time
spent
target
quadrant
0.01)
Considering
all
findings,
neuroprotective,
antioxidant,
metal-chelating
properties,
alongside
notable
efficacy
enhancing
models,
S.
could
be
potential
candidate
improvement.
International Journal of Innovative Technologies in Social Science,
Journal Year:
2025,
Volume and Issue:
2(46)
Published: May 19, 2025
This
review
evaluates
the
impact
of
cocoa
consumption,
particularly
flavanol-rich
dark
chocolate,
on
cognitive
function
based
evidence
from
25
human
studies.
A
structured
literature
search
was
conducted
in
PubMed
database
using
predefined
keywords,
and
relevant
studies
were
selected
according
to
methodological
quality
relevance.
Cognitive
domains
assessed
included
memory,
processing
speed,
executive
function,
visual
cognition.
Findings
randomized
controlled
trials
meta-analyses
indicate
modest
benefits,
especially
long-term
memory
primarily
among
middle-aged
older
adults
following
chronic
flavanol
intake.
Functional
neuroimaging
support
underlying
mechanisms
such
as
enhanced
cerebral
perfusion,
increased
neuronal
efficiency,
modulation
hippocampal
function.
Short-term
improvements
observed
episodic
spatial
reaction
time,
sensitivity.
However,
results
across
are
inconsistent.
Large-scale
trials,
notably
COSMOS
project,
reported
no
significant
benefits
daily
supplementation
general
population,
though
limited
noted
individuals
with
poor
dietary
quality.
Some
null
or
adverse
outcomes,
younger
when
combined
omega-3
fatty
acids.
In
conclusion,
intake
may
confer
specific
populations
contexts.
variation
study
design,
dosing,
baseline
characteristics
limits
generalizability.
Further
research
is
warranted
establish
optimal
regimens,
identify
responsive
subgroups,
determine
safety.